EyePoint, Inc. - Common Stock (EYPT)

CUSIP: 30233G209

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock
Shares outstanding
82,201,196
Total 13F shares
69,898,687
Share change
+742,877
Total reported value
$995,227,037
Put/Call ratio
88%
Price per share
$14.24
Number of holders
148
Value change
+$20,107,476
Number of buys
68
Number of sells
63

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 30233G209?
CUSIP 30233G209 identifies EYPT - EyePoint, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of EYPT - EyePoint, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
EW Healthcare Partners, L.P.
3/4/5
Other*, 10%+ Owner
class O/S missing
3,490,921
$87,327,483 01 Sep 2023
Cormorant Asset Management, LP
13F
Company
10%
8,325,000
$78,338,250 30 Jun 2025
13F
SUVRETTA CAPITAL MANAGEMENT, LLC
13F
Company
8.3%
6,804,091
$64,026,496 30 Jun 2025
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
8.3%
6,800,000
$63,988,000 30 Jun 2025
13F
BlackRock, Inc.
13D/G 13F
Company
6.5%
4,485,402
$63,872,124 $0 30 Sep 2025
FEDERATED HERMES, INC.
13D/G 13F
Company
6.7%
4,599,450
$43,281,744 $0 30 Jun 2025
FRANKLIN RESOURCES INC
13F 13D/G
Company
6.1%
from 13D/G
4,301,123
$40,473,570 30 Jun 2025
VANGUARD GROUP INC
13F
Company
4.6%
3,802,646
$35,782,900 30 Jun 2025
13F
TCG Crossover Management, LLC
13F
Company
4.3%
3,572,335
$33,615,672 30 Jun 2025
13F
CITADEL ADVISORS LLC
13F
Company
2.9%
2,344,210
$22,059,016 30 Jun 2025
13F
RA CAPITAL MANAGEMENT, L.P.
13D/G
4.7%
3,181,818
$20,809,090 $0 31 Dec 2024
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.9%
1,592,048
$14,984,449 30 Jun 2025
13F
STATE STREET CORP
13F
Company
1.8%
1,515,549
$14,261,316 30 Jun 2025
13F
Patient Square Capital LP
13F
Company
1.6%
1,352,837
$12,730,196 30 Jun 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
1.6%
1,280,692
$12,051,312 30 Jun 2025
13F
Essex Woodlands Management, Inc.
13F
Company
1.4%
1,169,857
$11,008,354 30 Jun 2025
13F
5AM Venture Management, LLC
13F
Company
1.3%
1,050,000
$9,880,500 30 Jun 2025
13F
Aberdeen Group plc
13F
Company
1.3%
1,031,201
$9,703,601 30 Jun 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.99%
814,153
$7,661,184 30 Jun 2025
13F
MORGAN STANLEY
13F
Company
0.95%
782,642
$7,364,661 30 Jun 2025
13F
HSBC HOLDINGS PLC
13F
Company
0.77%
631,074
$5,944,652 30 Jun 2025
13F
Nantahala Capital Management, LLC
13F
Company
0.72%
593,091
$5,580,986 30 Jun 2025
13F
Blue Owl Capital Holdings LP
13F
Company
0.68%
562,594
$5,294,010 30 Jun 2025
13F
Principia Wealth Advisory, LLC
13F
Company
0.65%
533,778
$5,022,851 30 Jun 2025
13F
NORTHERN TRUST CORP
13F
Company
0.63%
515,613
$4,851,918 30 Jun 2025
13F
DEUTSCHE BANK AG\
13F
Company
0.62%
512,113
$4,818,984 30 Jun 2025
13F
Woodline Partners LP
13F
Company
0.61%
500,335
$4,708,152 30 Jun 2025
13F
FMR LLC
13F
Company
0.54%
446,305
$4,199,732 30 Jun 2025
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.46%
376,776
$3,545,462 30 Jun 2025
13F
Alyeska Investment Group, L.P.
13F
Company
0.43%
351,348
$3,306,185 30 Jun 2025
13F
Granahan Investment Management, LLC
13F
Company
0.41%
340,984
$3,208,659 30 Jun 2025
13F
STEMPOINT CAPITAL LP
13F
Company
0.4%
329,254
$3,098,280 30 Jun 2025
13F
Artia Global Partners LP
13F
Company
0.39%
316,700
$2,980,147 30 Jun 2025
13F
SCHRODER INVESTMENT MANAGEMENT GROUP
13F
Company
0.38%
313,979
$2,954,542 30 Jun 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.34%
281,115
$2,645,292 30 Jun 2025
13F
Therapeutics Ocumension
3/4/5
Director
class O/S missing
100,221
$2,507,088 11 Jan 2024
Ye Liu
3/4/5
Director
class O/S missing
100,221
$2,507,088 11 Jan 2024
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.32%
265,109
$2,494,676 30 Jun 2025
13F
AXA S.A.
13F
Company
0.32%
263,233
$2,477,023 30 Jun 2025
13F
Bleichroeder LP
13F
Company
0.31%
256,515
$2,413,806 30 Jun 2025
13F
MYDA Advisors LLC
13F
Company
0.3%
250,000
$2,352,500 30 Jun 2025
13F
JPMORGAN CHASE & CO
13F
Company
0.3%
247,412
$2,328,147 30 Jun 2025
13F
ROYAL BANK OF CANADA
13F
Company
0.27%
225,964
$2,126,000 30 Jun 2025
13F
Bank of New York Mellon Corp
13F
Company
0.25%
207,702
$1,954,474 30 Jun 2025
13F
Walleye Capital LLC
13F
Company
0.24%
199,449
$1,876,815 30 Jun 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.23%
189,878
$1,786,752 30 Jun 2025
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0.21%
172,446
$1,622,717 30 Jun 2025
13F
David Scott Jones
3/4/5
SVP & Chief Commercial Officer
mixed-class rows
54,291
mixed-class rows
$1,437,581 09 Feb 2024
Dario A. Paggiarino
3/4/5
Chief Medical Officer
mixed-class rows
68,106
mixed-class rows
$1,386,544 30 Mar 2024
XTX Topco Ltd
13F
Company
0.17%
137,950
$1,298,110 30 Jun 2025
13F

Institutional Holders of EyePoint, Inc. - Common Stock (EYPT) as of Q3 2025

As of 30 Sep 2025, EyePoint, Inc. - Common Stock (EYPT) was held by 148 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 69,898,687 shares. The largest 10 holders included Cormorant Asset Management, LP, SUVRETTA CAPITAL MANAGEMENT, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock, Inc., FEDERATED HERMES, INC., FRANKLIN RESOURCES INC, VANGUARD GROUP INC, TCG Crossover Management, LLC, CITADEL ADVISORS LLC, and Paradigm Biocapital Advisors LP. This page lists 148 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
139
Q3 2025 holders
148
Holder diff
9
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 Value $ Q3 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.